These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21712613)

  • 1. Chronopharmacological assessment identified GLUT4 as a factor responsible for the circadian variation of the hypoglycemic effect of tolbutamide in rats.
    Miyazaki M; Fujii T; Takeda N; Magotani H; Iwanaga K; Kakemi M
    Drug Metab Pharmacokinet; 2011; 26(5):503-15. PubMed ID: 21712613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ginkgo biloba extract on the pharmacokinetics and pharmacodynamics of tolbutamide in protein-restricted rats.
    Taki Y; Hagiwara E; Hirose C; Shinozuka K; Umegaki K; Yamada S
    J Pharm Pharmacol; 2011 Sep; 63(9):1238-43. PubMed ID: 21827497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro.
    Müller G; Wied S
    Diabetes; 1993 Dec; 42(12):1852-67. PubMed ID: 8243832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats.
    Nishimura N; Naora K; Hirano H; Iwamoto K
    J Pharm Pharmacol; 1998 Feb; 50(2):231-6. PubMed ID: 9530993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Jatrorrhizine regulates GLUTs with multiple manners for hypoglycemic effect in insulin-resistance 3T3-L1 adipocytes].
    Zhu SL; Lei T; Gao X; Tu J
    Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1215-1220. PubMed ID: 29676131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.
    Terasaki J; Anai M; Funaki M; Shibata T; Inukai K; Ogihara T; Ishihara H; Katagiri H; Onishi Y; Sakoda H; Fukushima Y; Yazaki Y; Kikuchi M; Oka Y; Asano T
    Diabetologia; 1998 Apr; 41(4):400-9. PubMed ID: 9562343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent hypoglycemia is induced by tolbutamide administration in broiler chickens fed a low-carbohydrate diet.
    Seki Y; Sato K; Ohtsu H; Akiba Y
    Domest Anim Endocrinol; 2001 Feb; 20(2):109-22. PubMed ID: 11311849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.
    Stevenson RW; McPherson RK; Persson LM; Genereux PE; Swick AG; Spitzer J; Herbst JJ; Andrews KM; Kreutter DK; Gibbs EM
    Diabetes; 1996 Jan; 45(1):60-6. PubMed ID: 8522061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal protein restriction during early lactation induces GLUT4 translocation and mTOR/Akt activation in adipocytes of adult rats.
    Garcia-Souza EP; da Silva SV; Félix GB; Rodrigues AL; de Freitas MS; Moura AS; Barja-Fidalgo C
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E626-36. PubMed ID: 18559980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats.
    Shimaya A; Noshiro O; Hirayama R; Yoneta T; Niigata K; Shikama H
    Eur J Endocrinol; 1997 Dec; 137(6):693-700. PubMed ID: 9437239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate but not long-term administration of nicardipine inhibits tolbutamide-induced insulin secretion from rat pancreatic beta cells.
    Liu CQ; Li XJ; Zhang W; Zhang HJ; Lin MZ; Yang SY
    Pancreas; 2010 May; 39(4):452-7. PubMed ID: 19959966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain.
    Toide K; Man ZW; Asahi Y; Sato T; Nakayama N; Noma Y; Oka Y; Shima K
    Diabetes Res Clin Pract; 1997 Dec; 38(3):151-60. PubMed ID: 9483380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment.
    Tordjman KM; Leingang KA; James DE; Mueckler MM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7761-5. PubMed ID: 2682625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and the insulin-releasing drug tolbutamide attenuate the effects of morphine and angiotensin on alcohol consumption.
    Grupp LA; Hsu G; Ng N; Harding S
    Alcohol; 1997; 14(1):71-9. PubMed ID: 9014027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats.
    Yaspelkis BB; Davis JR; Saberi M; Smith TL; Jazayeri R; Singh M; Fernandez V; Trevino B; Chinookoswong N; Wang J; Shi ZQ; Levin N
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E130-42. PubMed ID: 11120667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coleus forskohlii extract attenuates the hypoglycemic effect of tolbutamide in vivo via a hepatic cytochrome P450-mediated mechanism.
    Yokotani K; Chiba T; Sato Y; Umegaki K
    Shokuhin Eiseigaku Zasshi; 2014; 55(2):73-8. PubMed ID: 24990552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based modeling to demonstrate extrapancreatic effects of tolbutamide.
    Rostami-Hodjegan A; Peacey SR; George E; Heller SR; Tucker GT
    Am J Physiol; 1998 Apr; 274(4):E758-71. PubMed ID: 9575839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance.
    de Souza CJ; Yu JH; Robinson DD; Ulrich RG; Meglasson MD
    Diabetes; 1995 Aug; 44(8):984-91. PubMed ID: 7622005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals.
    Sato Y; Nishikawa M; Shinkai H; Sukegawa E
    Diabetes Res Clin Pract; 1991 Apr; 12(1):53-9. PubMed ID: 1906797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.